bmjopen-2016-011824O H, Maruyama I, Shimazaki S, Yamamoto bmjopen-2016-011824 Abstract(s)">PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/12711626 Y, Aikawa N, Ohno R, et al. Efficacy and safety of recombinant human soluble thrombomodulin (ART-123) in disseminated intravascular coagulation: results of a phase III, randomized, double-blind clinical trial. J Thromb Haemost. 2007;5:31?1. Levi M. The coagulant response in sepsis. Clin Chest Med. 2008;29:627?2. Sawdey M, Podor TJ, Loskutoff DJ. Regulation of type 1 plasminogen activator inhibitor gene expression in cultured bovine aortic endothelial cells. Induction by transforming growth factor-beta, lipopolysaccharide, and tumor necrosis factor-alpha. J Biol Chem. 1989;264:10396?01. Madoiwa S, Nunomiya S, Ono T, Shintani Y, Ohmori T, Mimuro J, et al. Plasminogen activator inhibitor 1 promotes a poor prognosis in sepsisinduced disseminated intravascular coagulation. Int J Hematol. 2006;84:398?05. Koyama K, Madoiwa S, Nunomiya S, Koinuma T, Wada M, Sakata A, et al. Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study. Crit Care. 2014;18:R13. Sawamura A, Hayakawa M, Gando S, Kubota N, Methyl 2-((4-nitro-1h-pyrazol-1-yl)methyl)benzoate Sugano M, Wada T, et al. Disseminated intravascular coagulation with a fibrinolytic phenotype at an early phase of trauma predicts mortality. Thromb Res. 2009;124:608?3. Palmer L, Martin L. Traumatic coagulopathy art 1: pathophysiology and diagnosis. J Vet Emerg Crit Care. 2014;24:63?4. Matthay MA. Severe sepsis new treatment with both anticoagulant and antiinflammatory properties. N Engl J Med. 2001;344:759?2. Weiss SJ. Tissue destruction by neutrophils. N Engl J Med. 1989;320:365?6. Dokai M, Madoiwa S, Yasumoto A, Kashiwakura Y, Ishiwata A, Sakata A, et al. Local 1-(Cyclopropylsulfonyl)-1,4-diazepane regulation of neutrophil elastase activity by endogenous alpha1-antitrypsin in lipopolysaccharide-primed hematological cells. Thromb Res. 2011;128:283?2. Moir E, Robbie LA, Bennett B, Booth NA. Polymorphonuclear leucocytes have two opposing roles in fibrinolysis. Thromb Haemost. 2002;87:1006?0. Wu K, Urano T, Ihara H, Takada Y, Fujie M, Shikimori M, et al. The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood. 1995;86:1056?1. Bach-Gansmo ET, Halvorsen S, Godal HC, Skjonsberg OH. Impaired clot lysis in the presence of human neutrophil elastase. Thromb Res. 1995;80:153?. Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347:589?00. Ono T, Mimuro J, Madoiwa S, Soejima K, Kashiwakura Y, Ishiwata A, et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/3081428 intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107:528?4. Xu J, Zhang X, Pelayo R, Monestier M, Ammollo CT, Semeraro F, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15:1318?1. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol. 2010;191:677?1. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A. 2010;107:15880?. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases.